Cresset Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,327
Closed -$578K 1888
2024
Q4
$578K Sell
11,327
-15,272
-57% -$751K ﹤0.01% 1019
2024
Q3
$1.1M Sell
26,599
-232
-0.9% -$11.1K ﹤0.01% 1122
2024
Q2
$1.29M Buy
26,831
+14,194
+112% +$629K 0.01% 932
2024
Q1
$606K Buy
12,637
+2,965
+31% +$158K ﹤0.01% 1243
2023
Q4
$628K Buy
9,672
+61
+0.6% +$3.67K ﹤0.01% 1106
2023
Q3
$629K Buy
9,611
+299
+3% +$18.8K ﹤0.01% 1057
2023
Q2
$541K Buy
9,312
+5,027
+117% +$317K ﹤0.01% 1237
2023
Q1
$265K Buy
+4,285
New +$257K 0.01% 671

Other funds holding NARI

Cresset Asset Management's NARI Position: Q1 2025 in Review

Cresset Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 11,327 shares — an estimated $578K sold.

Cresset Asset Management first reported a position in NARI in Q1 2023 and held it in 8 quarters. The position peaked at $1.29M in Q2 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Cresset Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Cresset Asset Management sold 11,327 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $578K.
  • Cresset Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2023 and held it in 8 quarters.
  • Cresset Asset Management's Inari Medical, Inc. Common Stock position peaked at $1.29M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Cresset Asset Management's 13F filing for Q1 2025, filed 13 May 2025.